Your session is about to expire
← Back to Search
Procedure
Adolescent Overweight for Type 1 Diabetes (T1D Trial)
N/A
Waitlist Available
Led By Michelle Van Name, MD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 240 minutes
Awards & highlights
T1D Trial Summary
This trial will look at how extra weight (adiposity) affects insulin's ability to control blood sugar in obese adolescents with type 1 diabetes. It will also examine how fatty liver disease affects insulin resistance in these teens.
Eligible Conditions
- Type 1 Diabetes
- Obesity
T1D Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 240 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~240 minutes
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Hepatic Sensitivity to Low Dose Insulin
Peripheral Sensitivity to High Dose Insulin
Rate of Glucose Metabolism
+1 moreT1D Trial Design
3Treatment groups
Experimental Treatment
Group I: Young AdultExperimental Treatment1 Intervention
Young adults with T1D with a euglycemic hyperinsulinemic clamp with tracer enhancement
Group II: Adolescent TypicalExperimental Treatment1 Intervention
Lean adolescents with T1D
Group III: Adolescent OverweightExperimental Treatment1 Intervention
Adolescents with T1D and overweight/obesity
Find a Location
Who is running the clinical trial?
Yale UniversityLead Sponsor
1,863 Previous Clinical Trials
2,742,558 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,377 Previous Clinical Trials
4,315,788 Total Patients Enrolled
Michelle Van Name, MDPrincipal InvestigatorYale University
2 Previous Clinical Trials
69 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger